Alnylam Pharmaceuticals
ALNY
#637
Rank
โ‚น3.799 T
Marketcap
โ‚น28,460
Share price
-1.02%
Change (1 day)
15.20%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company